Agenus Announces Virtual Annual Shareholders Meeting
June 05 2023 - 7:30AM
Business Wire
Agenus (NASDAQ: AGEN), a leading immuno-oncology company with a
pipeline of immunological agents targeting cancer and infectious
disease, today announced that its Annual Shareholders Meeting will
begin at 10:30 a.m. ET on June 12, 2023 and will be conducted in a
virtual format only. Registration for attendees will start at 10:15
a.m. ET.
To participate in the Annual Shareholders Meeting, shareholders
should visit http://www.virtualshareholdermeeting.com/AGEN2023 and
enter the 16-digit control number found in their proxy materials.
Guests may also access the Annual Shareholders Meeting, but in
listen-only mode. No control number is required for guests.
Webcast Information: Date: Monday, June 12, 2023 Time:
10:30 a.m. ET
A live webcast and replay will be accessible from the Company's
website at https://investor.agenusbio.com/events-and-presentations
and at http://www.virtualshareholdermeeting.com/AGEN2023.
About Agenus
Agenus is a clinical-stage immuno-oncology company focused on
developing therapies that engage the body's immune system in
fighting cancer and infections. The Company's mission is to broaden
the patient populations benefiting from cancer immunotherapy
through combination approaches, leveraging a broad repertoire of
antibody therapeutics, adoptive cell therapies (through its
subsidiary MiNK Therapeutics), and adjuvants (through its
subsidiary SaponiQx). Agenus is headquartered in Lexington, MA. For
more information, please visit www.agenusbio.com and our Twitter
handle @agenus_bio.
Information that may be important to investors will be routinely
posted on our website and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230605005037/en/
Agenus Inc. Zack Armen Head of Investor Relations 917-362-1370
zack.armen@agenusbio.com
Agenus (NASDAQ:AGEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agenus (NASDAQ:AGEN)
Historical Stock Chart
From Sep 2023 to Sep 2024